Search - tctmd.com

Displaying 1 - 20 of 26

Sort: Relevancy | Date

News Conference News AHA 2025

Artificial Intelligence Successfully Adjudicates Clinical Events in CV Trials

Yael L. Maxwell

November 13, 2025

News Daily News

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Michael O'Riordan

August 01, 2025

News Daily News

Cannabis Use Again Tied to Increased CVD Risk in Young People

L.A. McKeown

March 19, 2025

News Daily News

DOACs Reduce Stroke, Increase Bleeding in ICH Survivors With AF

Todd Neale

March 06, 2025

News Daily News

COVID-19 Increases MACE Risk Nearly 3 Years Later: UK Biobank

Todd Neale

October 10, 2024

News Daily News

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

L.A. McKeown

August 19, 2024

News Conference News ESOC 2024

Colchicine Misses in Secondary Stroke Prevention, but Door Not Closed Yet

Todd Neale

May 16, 2024

News Opinion CV Team Dispatch

March 2024 Dispatch for the CV Team

L.A. McKeown

March 01, 2024

News Daily News

Salt Substitute Slashes New Hypertension Diagnoses: DECIDE-Salt

L.A. McKeown

February 14, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2023

Shelley Wood

March 01, 2023

News Conference News ESC 2022

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

L.A. McKeown

August 30, 2022

News Conference News EuroPCR 2022

Registry Data Hint at MACE Benefit With Renal Denervation

Michael O'Riordan

May 17, 2022

News Daily News

Recurrent Stroke Risk Lower With More Intense LDL-Lowering: Meta-analysis

Yael L. Maxwell

March 01, 2022

News Opinion CV Team Dispatch

December 2021 News Roundup

L.A. McKeown

December 01, 2021

News Conference News ESC 2021

Massive SSaSS Study Shows Switch to Salt Substitute Cuts Stroke, CVD

Michael O'Riordan

August 29, 2021

News Daily News

OMT Boosts Survival in Revascularized Patients at 10 Years

Michael O'Riordan

June 29, 2021

News Opinion CV Team Dispatch

June 2021 News Roundup

L.A. McKeown

June 01, 2021

News Conference News ACC 2021

Rivaroxaban Helps Prevent More Events Than Aspirin Alone After Leg Interventions

L.A. McKeown

May 21, 2021

News Daily News

Short DAPT Bests Aspirin at Preventing Recurrent Events After Stroke, TIA

Yael L. Maxwell

April 29, 2021

News Opinion CV Team Dispatch

March 2020 News Roundup

L.A. McKeown

March 12, 2020

Advertisement

Artificial Intelligence Successfully Adjudicates Clinical Events in CV Trials

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Cannabis Use Again Tied to Increased CVD Risk in Young People

DOACs Reduce Stroke, Increase Bleeding in ICH Survivors With AF

COVID-19 Increases MACE Risk Nearly 3 Years Later: UK Biobank

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

Colchicine Misses in Secondary Stroke Prevention, but Door Not Closed Yet

March 2024 Dispatch for the CV Team

Salt Substitute Slashes New Hypertension Diagnoses: DECIDE-Salt

TCTMD’s Top 10 Most Popular Stories for February 2023

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

Registry Data Hint at MACE Benefit With Renal Denervation

Recurrent Stroke Risk Lower With More Intense LDL-Lowering: Meta-analysis

December 2021 News Roundup

Massive SSaSS Study Shows Switch to Salt Substitute Cuts Stroke, CVD

OMT Boosts Survival in Revascularized Patients at 10 Years

June 2021 News Roundup

Rivaroxaban Helps Prevent More Events Than Aspirin Alone After Leg Interventions

Short DAPT Bests Aspirin at Preventing Recurrent Events After Stroke, TIA

March 2020 News Roundup

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content